Skip to content
Single Family OfficeInvests its own capital directly in companiesLAST VERIFIED Oct 2026 · 9 SOURCES

Enthéos

Also known as Entheos, Enthéos Investissement, ENTHEOS SAS

Evergreen family office of the Parmentier family (Rennes) taking majority or minority stakes of €2–15M in French SMEs with €5–50M EBITDA, in buyout and growth deals.

USEFUL FOR Business owners seeking a long-term partner · Co-investors

Family & background

FAMILY
Parmentier
HEADQUARTERS
Rennes, France

Investment approach

SECTORS
HealthTechClimate & EnergyIndustrial & ManufacturingFood & AgricultureSoftware & SaaSConsumer & E-commerce
GEOGRAPHY
France
STAGES
GrowthBuyout
ROUTES
Companies (own capital)
STRATEGIES
Direct investmentsPrivate equity
TICKET
€2M–€15M

Overview

Enthéos is an evergreen investment holding that its website says was born of the entrepreneurial history of the Parmentier family; its own press releases call it “le Family Office Enthéos”. It invests directly in SMEs with €5–50M EBITDA, in buyout or growth deals, as lead or co-investor, with €2–15M tickets in equity or flex equity, as majority or reference minority shareholder. It has teams in Paris, Lyon and Rennes and aims for its whole portfolio to be compatible with a “sober, living and resilient” world by 2030. Its portfolio page lists 14 current holdings, including Virtuos, Simpliciti, Aktid, Filab, Mitem Pharma, Olyos and MIR.

Holdings & investments (17)

  • VirtuosNOTABLE
    Media & Entertainment · since 2018
  • OlyosNOTABLE
    HealthTech · since 2025
  • MIR
    HealthTech · since 2025
  • Ancorius
    since 2025
  • Haudecoeur
    Food & Agriculture · since 2024
  • Simpliciti
    Software & SaaS · since 2023
  • Aktid
    Industrial & Manufacturing · since 2023
  • Novetio
    Real Estate & PropTech · since 2023
  • Lumicène
    Consumer & E-commerce · since 2022
  • Filab
    Industrial & Manufacturing · since 2022
  • Mitem Pharma
    HealthTech · since 2022
  • X-Path
    HealthTech · since 2021
  • Vivalto
    HealthTech · since 2021 · Exited
  • Seguin
    Climate & Energy · since 2019
  • Thomas Plants
    Food & Agriculture · since 2019
  • E-loft
    Real Estate & PropTech · since 2018 · Acquired
  • Domidep
    HealthTech · since 2017 · Exited

People

  • Guillaume de Gottal
    Investment Director · source
  • Hugo Robiliard
    Investment Director (team list; bio says Investment Manager) · source
  • Pierre Jolly
    Investment Manager (team list; bio says Analyste) · source
  • Antoine Doublet
    Investment Manager (team list; older bio says Analyste stagiaire) · source
  • Olivier Parmentier
    Partner; heads Enthéos · source
  • Kathrin Parmentier
    Partner · source
  • Olivier Verneau
    Chief Financial Officer · source

Frequently asked questions

Enthéos is a single family office based in Rennes, France.

Enthéos invests on behalf of the Parmentier family.

Enthéos invests directly in companies. Capital origin: one family's own capital. Stated strategies include direct investments and private equity.

Enthéos invests at Growth and Buyout stages in HealthTech, Climate & Energy, Industrial & Manufacturing, Food & Agriculture, Software & SaaS and Consumer & E-commerce.

Enthéos's stated ticket size is €2M–€15M.

Key people at Enthéos include Olivier Parmentier (Partner; heads Enthéos), Kathrin Parmentier (Partner), Guillaume de Gottal (Investment Director) and Hugo Robiliard (Investment Director (team list; bio says Investment Manager)).

Enthéos's disclosed holdings and investments include Virtuos, Olyos, Lumicène, Simpliciti, Aktid, Novetio, Filab and Mitem Pharma, among others.